These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35479095)

  • 1. A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques.
    Volkmann A; Koopman G; Mooij P; Verschoor EJ; Verstrepen BE; Bogers WMJM; Idorn M; Paludan SR; Vang S; Nielsen MA; Sander AF; Schmittwolf C; Hochrein H; Chaplin P
    Front Immunol; 2022; 13():857440. PubMed ID: 35479095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2.
    Smit MJ; Sander AF; Ariaans MBPA; Fougeroux C; Heinzel C; Fendel R; Esen M; Kremsner PG; Ter Heine R; Wertheim HF; Idorn M; Paludan SR; Underwood AP; Binderup A; Ramirez S; Bukh J; Soegaard M; Erdogan SM; Gustavsson T; Clemmensen S; Theander TG; Salanti A; Hamborg M; de Jongh WA; McCall MBB; Nielsen MA; Mordmüller BG;
    Lancet Microbe; 2023 Mar; 4(3):e140-e148. PubMed ID: 36681093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
    He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
    Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.
    Wang S; Wang CY; Kuo HK; Peng WJ; Huang JH; Kuo BS; Lin F; Liu YJ; Liu Z; Wu HT; Ding S; Hou KL; Cheng J; Yang YT; Jiang MH; Wang MS; Chen T; Xia WG; Lin E; Hung CH; Chen HJ; Shih Z; Lin YL; Ryan V; Hu MM; Heppner DG; Malherbe DC; Periasamy S; Kuzmina N; Subramani C; Hellerstein M; Monath TP; Rumyantsev A; Bukreyev A; Guirakhoo F
    Emerg Microbes Infect; 2022 Dec; 11(1):2724-2734. PubMed ID: 36287714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates.
    He Q; Mao Q; Peng X; He Z; Lu S; Zhang J; Gao F; Bian L; An C; Yu W; Yang F; Zhou Y; Yang Y; Li Y; Yuan Y; Yan X; Yang J; Wu X; Huang W; Li C; Wang J; Liang Z; Xu M
    Signal Transduct Target Ther; 2022 Mar; 7(1):69. PubMed ID: 35241645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
    Yu J; Tostanoski LH; Peter L; Mercado NB; McMahan K; Mahrokhian SH; Nkolola JP; Liu J; Li Z; Chandrashekar A; Martinez DR; Loos C; Atyeo C; Fischinger S; Burke JS; Slein MD; Chen Y; Zuiani A; Lelis FJN; Travers M; Habibi S; Pessaint L; Van Ry A; Blade K; Brown R; Cook A; Finneyfrock B; Dodson A; Teow E; Velasco J; Zahn R; Wegmann F; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kirilova M; Kordana N; Lin Z; Maxfield LF; Nampanya F; Nityanandam R; Ventura JD; Wan H; Cai Y; Chen B; Schmidt AG; Wesemann DR; Baric RS; Alter G; Andersen H; Lewis MG; Barouch DH
    Science; 2020 Aug; 369(6505):806-811. PubMed ID: 32434945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
    Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
    Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later.
    Milligan EC; Olstad K; Williams CA; Mallory M; Cano P; Cross KA; Munt JE; Garrido C; Lindesmith L; Watanabe J; Usachenko JL; Hopkins L; Immareddy R; Shaan Lakshmanappa Y; Elizaldi SR; Roh JW; Sammak RL; Pollard RE; Yee JL; Herbek S; Scobey T; Miehlke D; Fouda G; Ferrari G; Gao H; Shen X; Kozlowski PA; Montefiori D; Hudgens MG; Edwards DK; Carfi A; Corbett KS; Graham BS; Fox CB; Tomai M; Iyer SS; Baric R; Reader R; Dittmer DP; Van Rompay KKA; Permar SR; De Paris K
    Sci Transl Med; 2023 Mar; 15(685):eadd6383. PubMed ID: 36454813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    Yu J; Collins ND; Mercado NB; McMahan K; Chandrashekar A; Liu J; Anioke T; Chang A; Giffin VM; Hope DL; Sellers D; Nampanya F; Gardner S; Barrett J; Wan H; Velasco J; Teow E; Cook A; Van Ry A; Pessaint L; Andersen H; Lewis MG; Hofer C; Burke DS; Barkei EK; King HAD; Subra C; Bolton D; Modjarrad K; Michael NL; Barouch DH
    J Virol; 2022 Jan; 96(2):e0159921. PubMed ID: 34705557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection.
    Rappaport AR; Hong SJ; Scallan CD; Gitlin L; Akoopie A; Boucher GR; Egorova M; Espinosa JA; Fidanza M; Kachura MA; Shen A; Sivko G; Van Abbema A; Veres RL; Jooss K
    Nat Commun; 2022 Jun; 13(1):3289. PubMed ID: 35672369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.
    Li D; Luan N; Li J; Zhao H; Zhang Y; Long R; Jiang G; Fan S; Xu X; Cao H; Wang Y; Liao Y; Wang L; Liu L; Liu C; Li Q
    Emerg Microbes Infect; 2021 Dec; 10(1):2194-2198. PubMed ID: 34736354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
    Gooch KE; Smith TRF; Salguero FJ; Fotheringham SA; Watson RJ; Dennis MJ; Handley A; Humphries HE; Longet S; Tipton T; Sarfas C; Sibley L; Slack GS; Rayner E; Ryan KA; Schultheis K; Ramos SJ; White A; Charlton S; Sharpe SA; Gleeson F; Humeau LM; Hall Y; Broderick KE; Carroll MW
    Vaccine; 2021 Aug; 39(34):4885-4894. PubMed ID: 34253420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model.
    Patel A; Walters JN; Reuschel EL; Schultheis K; Parzych E; Gary EN; Maricic I; Purwar M; Eblimit Z; Walker SN; Guimet D; Bhojnagarwala P; Adeniji OS; Doan A; Xu Z; Elwood D; Reeder SM; Pessaint L; Kim KY; Cook A; Chokkalingam N; Finneyfrock B; Tello-Ruiz E; Dodson A; Choi J; Generotti A; Harrison J; Tursi NJ; Andrade VM; Dia Y; Zaidi FI; Andersen H; Abdel-Mohsen M; Lewis MG; Muthumani K; Kim JJ; Kulp DW; Humeau LM; Ramos SJ; Smith TRF; Weiner DB; Broderick KE
    Cell Rep Med; 2021 Oct; 2(10):100420. PubMed ID: 34604818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques.
    Liu Y; Zhang A; Wang Y; Yang J; Yin F; Wu S; Zhang Y; Jiang X; Zhu J; Gao W; Yang X; Wen H; Guo Q; Chen X; Zhang H; Shen E; Yang Z; Li Y; Chen D; Li L; Guo J; Du X; Shi Y; Fu S; Zhang H; Liu Y
    Vaccine; 2023 Aug; 41(36):5283-5295. PubMed ID: 37451875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and immunogenicity of SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta).
    Oh DQP; Grothe I; Lukaß H; Kreiter AK; Hoffmann M; Wegener D
    Sci Rep; 2023 Feb; 13(1):3274. PubMed ID: 36841887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2.
    Mooij P; García-Arriaza J; Pérez P; Lázaro-Frías A; Verstrepen BE; Böszörményi KP; Mortier D; Fagrouch Z; Kiemenyi-Kayere G; Niphuis H; Acar RF; Meijer L; Stammes MA; Kondova I; Verschoor EJ; GeurtsvanKessel CH; de Bruin E; Sikkema RS; Luczkowiak J; Delgado R; Montenegro D; Puentes E; Rodríguez E; Bogers WMJM; Koopman G; Esteban M
    Front Immunol; 2022; 13():845887. PubMed ID: 35371043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.
    Sulbaran G; Maisonnasse P; Amen A; Effantin G; Guilligay D; Dereuddre-Bosquet N; Burger JA; Poniman M; Grobben M; Buisson M; Dergan Dylon S; Naninck T; Lemaître J; Gros W; Gallouët AS; Marlin R; Bouillier C; Contreras V; Relouzat F; Fenel D; Thepaut M; Bally I; Thielens N; Fieschi F; Schoehn G; van der Werf S; van Gils MJ; Sanders RW; Poignard P; Le Grand R; Weissenhorn W
    Cell Rep Med; 2022 Feb; 3(2):100528. PubMed ID: 35233549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8
    Ishii H; Nomura T; Yamamoto H; Nishizawa M; Thu Hau TT; Harada S; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Suzuki T; Park ES; Ken M; Onodera T; Takahashi Y; Kusano K; Shimazaki R; Suzaki Y; Ami Y; Matano T
    Cell Rep Med; 2022 Feb; 3(2):100520. PubMed ID: 35233545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection.
    Pérez P; Lázaro-Frías A; Zamora C; Sánchez-Cordón PJ; Astorgano D; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2021; 12():824728. PubMed ID: 35154086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.